We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Seppic

News List

Akston Biosciences, Seppic Ink Commercial Supply Agreement contractpharma
July 30, 2021
Akston Biosciences, a developer of new classes of biologic therapeutics, has entered a commercial agreement with Seppic S.A., a supplier of specialty healthcare ingredients, for the supply of adjuvant for use in Akston’s COVID-19 Fc fusion protein ...
Akston Biosciences to Supply Seppic’s Adjuvant to Create Shelf-Stable COVID-19 Vaccine americanpharmaceuticalreview
July 22, 2021
announced a commercial agreement with Akston Biosciences Corporation Seppic S.A., a supplier of specialty healthcare ingredients, for the supply of adjuvant for use in Akston’s COVID-19 Fc fusion protein vaccine candidate, AKS-452.